Effect of creatine monohydrate in improving cellular energetics and muscle strength in ambulatory Duchenne muscular dystrophy patients: a randomized, placebo-controlled 31P MRS study
Banerjee B, Sharma U, Balasubramanian K, Kalaivani M, Kalra V, Jagannathan NR
Magnetic resonance imaging · 49 citas
Etiquetas de revisión
Financiación no declaradaDatos neutrales que nuestra revisión registró sobre cómo se hizo este estudio. Describen el método, nunca si nos gusta el resultado.
Cómo se estudió
- Diseño
- Ensayo controlado aleatorizado (indexado por PubMed)
- Estudiado en
- Personas
- Resultado principal
- Marcadores de salud y funcionamiento
Quién lo pagó
- Financiación
- Financiación no declarada
Publicación
- Publicado
- 2010-04-16 · Magn Reson Imaging · vol. 28 · número 5 · págs. 698–707
- Editorial
- Elsevier BV
- Citado
- 68 citas · más que el 85% de estudios similares · 2.0× el promedio de su campo
- Referencias
- 47 trabajos
- Acceso
- De pago
- Áreas de investigación
- Muscle metabolism and nutrition · Muscle Physiology and Disorders · Neurogenetic and Muscular Disorders Research
- Palabras clave
- creatine monohydrate supplementation, Duchenne muscular dystrophy, cellular energetics, phosphocreatine, phosphocreatine to inorganic phosphate ratio, muscle energy metabolism, muscle strength, manual muscle testing, triceps surae, phosphodiester, phosphotriesters, functional status, outpatients, tolerability, 31P NMR
- MeSH
- muscle, skeletal, humans, muscular dystrophy, duchenne, phosphorus, phosphorus isotopes, creatine, magnetic resonance spectroscopy, placebo effect, child, child, preschool, female, male, muscle strength
6 autores
- Bidisha Banerjee🇮🇳All India Institute of Medical Sciences
- Uma Sharma🇮🇳All India Institute of Medical Sciences
- Krithika Balasubramanian🇮🇳All India Institute of Medical Sciences
- Mani Kalaivani🇮🇳All India Institute of Medical Sciences
- Veena Kalra🇮🇳All India Institute of Medical Sciences
- Naranamangalam Raghunathan Jagannathan🇮🇳 · autor de correspondenciaAll India Institute of Medical Sciences
Resumen
El texto original del estudio, en el idioma en que se publicó.
Randomized, placebo-controlled single blinded study was carried out to evaluate the effect of oral creatine supplementation on cellular energetics, manual muscle test (MMT) score and functional status in steroid-naive, ambulatory boys suffering with Duchenne muscular dystrophy (DMD; n=33). Eighteen patients received creatine monohydrate (Cr; 5 g/day for 8 weeks), while 15 received placebo (500 mg of vitamin C). Phosphorus metabolite ratios were determined from the right calf muscle of patients using phosphorus magnetic resonance spectroscopy ((31)P MRS) both prior to (baseline) and after supplementation of Cr or placebo. In addition, metabolite ratios were determined in normal calf muscle of age and sex matched controls (n=8). Significant differences in several metabolite ratios were observed between controls and DMD patients indicating a lower energy state in these patients. Analysis using analysis of covariance adjusted for age and stature showed that the mean phosphocreatine (PCr)/inorganic phosphate (Pi) ratio in patients treated with Cr (4.7; 95% CI; 3.9-5.6) was significantly higher (P=.03) compared to the placebo group (3.3; 95% CI; 2.5-4.2). The mean percentage increase in PCr/Pi ratio was also more in patients 7 years), after supplementation. These results imply that the significant difference observed in PCr/Pi ratio between the Cr and the placebo groups after supplementation may be attributed to a decrease of PCr in the placebo group and an increase in PCr in the Cr group. Changes in MMT score between the two groups was significant (P=.04); however, no change in functional scale (P=.19) was observed. Parents reported subjective improvement on Cr supplementation versus worsening in placebo (P=.02). Our results indicated that Cr was well tolerated and oral Cr significantly improved the muscle PCr/Pi ratio and preserved the muscle strength in short term. However, this study provides no evidence that creatine will prove beneficial after long-term treatment, or have any positive effect on patient lifespan.
Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.
Confianza de la comunidad
Cargando…
¿Cuánto confías en los hallazgos de este estudio?
Comentarios
¿Algo está mal aquí?
Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.
Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.